CN1204134C - 氨磺酰－取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物 - Google Patents

氨磺酰－取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物 Download PDF

Info

Publication number
CN1204134C
CN1204134C CNB971115400A CN97111540A CN1204134C CN 1204134 C CN1204134 C CN 1204134C CN B971115400 A CNB971115400 A CN B971115400A CN 97111540 A CN97111540 A CN 97111540A CN 1204134 C CN1204134 C CN 1204134C
Authority
CN
China
Prior art keywords
amino
methyl
sulphonyl
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB971115400A
Other languages
English (en)
Chinese (zh)
Other versions
CN1169429A (zh
Inventor
H·J·朗
U·杰拉克
J·布伦德尔
H·C·恩格勒特
H·格吉雷恩
M·洛珀特
H·博恩
A·赫林
A·布希
R·格雷杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19619614A external-priority patent/DE19619614A1/de
Priority claimed from DE1996139462 external-priority patent/DE19639462A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CN1169429A publication Critical patent/CN1169429A/zh
Application granted granted Critical
Publication of CN1204134C publication Critical patent/CN1204134C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB971115400A 1996-05-15 1997-05-13 氨磺酰－取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物 Expired - Fee Related CN1204134C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19619614.0 1996-05-15
DE19619614A DE19619614A1 (de) 1996-05-15 1996-05-15 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1996139462 DE19639462A1 (de) 1996-09-26 1996-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19639462.7 1996-09-26

Publications (2)

Publication Number Publication Date
CN1169429A CN1169429A (zh) 1998-01-07
CN1204134C true CN1204134C (zh) 2005-06-01

Family

ID=26025736

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB971115400A Expired - Fee Related CN1204134C (zh) 1996-05-15 1997-05-13 氨磺酰－取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物

Country Status (23)

Country Link
EP (1) EP0807629B1 (OSRAM)
JP (1) JP4234798B2 (OSRAM)
KR (1) KR100547921B1 (OSRAM)
CN (1) CN1204134C (OSRAM)
AR (2) AR007115A1 (OSRAM)
AT (1) ATE260909T1 (OSRAM)
AU (1) AU711986B2 (OSRAM)
BR (1) BR9703161A (OSRAM)
CA (1) CA2205477A1 (OSRAM)
CZ (1) CZ149497A3 (OSRAM)
DE (1) DE59711352D1 (OSRAM)
DK (1) DK0807629T3 (OSRAM)
ES (1) ES2218617T3 (OSRAM)
HR (1) HRP970255B1 (OSRAM)
HU (1) HUP9700903A3 (OSRAM)
IL (1) IL120827A (OSRAM)
NO (1) NO315556B1 (OSRAM)
NZ (1) NZ314800A (OSRAM)
PL (1) PL191330B1 (OSRAM)
PT (1) PT807629E (OSRAM)
SK (1) SK283837B6 (OSRAM)
TR (1) TR199700369A2 (OSRAM)
TW (1) TW496866B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329200A (en) * 1996-12-16 1999-05-28 Hoechst Ag Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments
DE19705133A1 (de) * 1997-02-11 1998-08-13 Hoechst Ag Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0895994A3 (de) 1997-08-05 1999-12-15 Hoechst Marion Roussel Deutschland GmbH Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CA2341678C (en) * 1998-09-01 2009-10-13 Bristol-Myers Squibb Company Potassium channel inhibitors and method
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
KR101019402B1 (ko) * 2004-03-23 2011-03-07 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물
US7884109B2 (en) 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
US7989459B2 (en) 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
TW200831104A (en) 2006-10-04 2008-08-01 Pharmacopeia Inc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
WO2008043019A1 (en) 2006-10-04 2008-04-10 Pharmacopeia, Inc 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression
US7902187B2 (en) 2006-10-04 2011-03-08 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
KR101703202B1 (ko) * 2009-04-30 2017-02-06 닛산 가가쿠 고교 가부시키 가이샤 3환성 벤조피란 화합물의 신규한 결정형태 및 그 제조방법
TWI583677B (zh) * 2012-09-21 2017-05-21 日本臟器製藥股份有限公司 香豆素衍生物
CN103012380B (zh) * 2013-01-10 2015-03-04 山东大学 一种色满类化合物及其制备方法与应用
JP6089055B2 (ja) * 2014-03-20 2017-03-01 日本臓器製薬株式会社 クマリン誘導体を含有する医薬
AR117169A1 (es) 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas
BR112022022595A2 (pt) 2020-05-06 2022-12-20 Bayer Ag Piridina (tio)amidas como compostos fungicidas
WO2021228734A1 (en) 2020-05-12 2021-11-18 Bayer Aktiengesellschaft Triazine and pyrimidine (thio)amides as fungicidal compounds
US20230192617A1 (en) 2020-05-19 2023-06-22 Bayer Cropscience Aktiengesellschaft Azabicyclic(thio)amides as fungicidal compounds
BR112022024086A2 (pt) 2020-05-27 2022-12-27 Bayer Ag Combinações de compostos ativos
WO2023078915A1 (en) 2021-11-03 2023-05-11 Bayer Aktiengesellschaft Bis(hetero)aryl thioether (thio)amides as fungicidal compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof

Also Published As

Publication number Publication date
CA2205477A1 (en) 1997-11-15
PL191330B1 (pl) 2006-04-28
JP4234798B2 (ja) 2009-03-04
NZ314800A (en) 1999-02-25
NO315556B1 (no) 2003-09-22
EP0807629B1 (de) 2004-03-03
SK60397A3 (en) 1998-02-04
AR007115A1 (es) 1999-10-13
AU711986B2 (en) 1999-10-28
HUP9700903A3 (en) 1999-03-01
HU9700903D0 (en) 1997-07-28
PL319995A1 (en) 1997-11-24
NO972211L (no) 1997-11-17
ES2218617T3 (es) 2004-11-16
SK283837B6 (sk) 2004-03-02
HK1006640A1 (en) 1999-03-12
ATE260909T1 (de) 2004-03-15
JPH1067772A (ja) 1998-03-10
DK0807629T3 (da) 2004-05-17
IL120827A (en) 2004-12-15
CZ149497A3 (en) 1997-12-17
HUP9700903A2 (hu) 1998-12-28
BR9703161A (pt) 1998-09-29
NO972211D0 (no) 1997-05-14
CN1169429A (zh) 1998-01-07
KR19980024020A (ko) 1998-07-06
IL120827A0 (en) 1997-09-30
HRP970255B1 (en) 2003-10-31
HRP970255A2 (en) 1998-04-30
DE59711352D1 (de) 2004-04-08
TR199700369A2 (xx) 1997-12-21
EP0807629A1 (de) 1997-11-19
PT807629E (pt) 2004-07-30
AR010314A1 (es) 2000-06-07
KR100547921B1 (ko) 2006-10-19
TW496866B (en) 2002-08-01
MX9703534A (es) 1997-11-29
AU2080697A (en) 1997-11-20

Similar Documents

Publication Publication Date Title
CN1204134C (zh) 氨磺酰－取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物
CN1129597C (zh) 杂环化合物和以其为有效成分的抗肿瘤剂
CN1128139C (zh) 新哌嗪衍生物及其制造方法
CN1184425A (zh) 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂
CN1113236A (zh) 非肽基速激肽受体拮抗剂
CN1727339A (zh) 三环化合物及其制备和用途
CN1865248A (zh) 咪唑－4－羧酰胺衍生物及其制备和用于治疗肥胖症的方法
CN1807426A (zh) 杂芳基脲神经肽yy5受体拮抗剂
CN1198804C (zh) 酰胺化合物及其用途
CN1582281A (zh) Mch受体拮抗剂
CN1553899A (zh) 抑制肝细胞生长因子受体自磷酸化的喹啉衍生物和喹唑啉衍生物以及含有这些化合物的药物组合物
CN1396833A (zh) 整联蛋白表达抑制剂
CN1295064A (zh) 新的三环化合物及含有它们的药物组合物
CN1653047A (zh) 抗炎症药物单环芳酰吡啶酮
CN1933830A (zh) 吲哚衍生物和其作为激酶抑制剂特别是ikk2抑制剂的用途
CN1028521C (zh) 治疗剂
CN1223652A (zh) 作为钠通道调节剂的环醚化合物
CN1617856A (zh) 取代的4－苯基四氢异喹啉、其制备方法、其用作药物的用途以及含有它们的药物
CN1036566A (zh) 1，3，4，5-四氢苯并[c，d]哚类化合物
CN1295563A (zh) 用作毒蕈碱性受体拮抗剂的2－芳基乙基－(哌啶－4－基甲基)胺衍生物
CN1031262C (zh) 环取代的2-氨基-1，2，3，4-四氢化萘和3-氨基苯并二氢吡喃
CN1085901A (zh) 制备含咪唑并哒嗪衍生物的抗肿瘤药物组合物的方法
CN1993344A (zh) 可用作香草素拮抗剂的色酮衍生物
CN1795179A (zh) 新的咪唑衍生物、其制备方法和其作为药物的用途
CN1950353A (zh) 治疗凝血紊乱的药物和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee